Byoung Chul Cho (Byoung C Cho)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 89

Top Venues

Nature

Clinical cancer research : an official journal of the American Association for Cancer Research

Therapeutic advances in medical oncology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Severance Hospital, Yonsei University Health System

Yonsei University College of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Severance Hospital, Yonsei University Health System

South Korea

PI/Professor :: Oncology

Education History

Yonsei University College of Medicine

South Korea

PHD :: Medical Oncology

Publications

Byoung Chul Cho, Irene Braña, Beatriz Cirauqui, Sercan Aksoy, Felix Couture, Ruey-Long Hong, Wilson H Miller, Manuel Chaves-Conde, Margarida Teixeira, Lance Leopold, Mihaela Munteanu, Joy Yang Ge, Ramona F Swaby, Brett G M Hughes
Pembrolizumab plus epacadostat in patients with recurrent/metastatic head and neck squamous cell carcinoma (KEYNOTE-669/ECHO-304): a phase 3, randomized, open-label study. BMC cancer 23 (Suppl 1) (2024)
Xiangnan Guan, Ruozhen Hu, Yoonha Choi, Shyam Srivats, Barzin Y Nabet, John Silva, Lisa McGinnis, Robert Hendricks, Katherine Nutsch, Karl L Banta, Ellen Duong, Alexis Dunkle, Patrick S Chang, Chia-Jung Han, Stephanie Mittman, Nandini Molden, Pallavi Daggumati, Wendy Connolly, Melissa Lynne Johnson, Delvys Rodriguez Abreu, Byoung Chul Cho, Antoine Italiano, Ignacio Gil-Bazo, Enriqueta Felip, Ira Mellman, Sanjeev Mariathasan, David S Shames, Raymond Meng, Eugene Y Chiang, Robert J Johnston, Namrata S Patil
Publisher Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T reg cells. Nature (2024)
Xiangnan Guan, Ruozhen Hu, Yoonha Choi, Shyam Srivats, Barzin Y Nabet, John Silva, Lisa McGinnis, Robert Hendricks, Katherine Nutsch, Karl L Banta, Ellen Duong, Alexis Dunkle, Patrick S Chang, Chia-Jung Han, Stephanie Mittman, Nandini Molden, Pallavi Daggumati, Wendy Connolly, Melissa Lynne Johnson, Delvys Rodriguez Abreu, Byoung Chul Cho, Antoine Italiano, Ignacio Gil-Bazo, Enriqueta Felip, Ira Mellman, Sanjeev Mariathasan, David S Shames, Raymond Meng, Eugene Y Chiang, Robert J Johnston, Namrata S Patil
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T reg cells. Nature 627 (8004) (2024)
Konstantin Penkov, Igor Bondarenko, Daria Viktorovna Saenko, Yaroslav Kulyaba, Jun Guo, Yi Gong, Noboru Yamamoto, Yevhen Stepanovych Hotko, Vasyl Boyko, Natalya Vladimirovna Fadeeva, Grygorii Mykolaiovych Ursol, Hee Kyung Ahn, Nikolay Viktorovich Kislov, Chia-I Shen, Craig Davis, Karey Kowalski, Elisabete Michelon, Dmitri Pavlov, Tomoko Hirohashi, Byoung Chul Cho
Pharmacokinetics, safety, and efficacy of an alternative dosing regimen of sasanlimab in participants with advanced NSCLC and other malignancies. Therapeutic advances in medical oncology 16 (2024)
Dahea Lee, Dongsu Kim, Donggeon Kim, Jisu Kang, Kiram Lee, Hyunji Lee, Yujin Yoon, Youngin Lee, Nahmju Kim, Byoung Chul Cho, Jihoon Chang, Byoung Chul Lee
Harnessing the Potential of FAP-IL-12mut TMEkine™ for Targeted and Enhanced Anti-tumor Responses. Molecular cancer therapeutics (2024)
Moonki Hong, Sang Wook Lee, Byoung Chul Cho, Min Hee Hong, Sun Min Lim, Nak-Jung Kwon
Multiplex analysis for the identification of plasma protein biomarkers for predicting lung cancer immunotherapy response. Therapeutic advances in medical oncology 16 (2024)
Jessica J Lin, Joshua C Horan, Anupong Tangpeerachaikul, Aurélie Swalduz, Augusto Valdivia, Melissa Lynne Johnson, Benjamin Besse, D Ross Camidge, Toshio Fujino, Satoshi Yoda, Linh Nguyen-Phuong, Hayato Mizuta, Ludovic Bigot, Catline Nobre, Jii Bum Lee, Mi Ra Yu, Scot Mente, Yuting Sun, Nancy E Kohl, James R Porter, Matthew D Shair, Viola W Zhu, Enriqueta Felip Font, Byoung Chul Cho, Luc Friboulet, Aaron N Hata, Henry E Pelish, Alexander E Drilon
NVL-655 Is a Selective and Brain-Penetrant Inhibitor of Diverse ALK-Mutant Oncoproteins, Including Lorlatinib-Resistant Compound Mutations. Cancer discovery (2024)
Seul Lee, Yunjoo Joo, Eun Ji Lee, Youngseon Byeon, Jae-Hwan Kim, Kyoung-Ho Pyo, Young Seob Kim, Sun Min Lim, Peter Kilbride, Rohin K Iyer, Mingming Li, Mandy C French, Jung-Yub Lee, Jeeheon Kang, Hyesin Byun, Byoung Chul Cho
Successful expansion and cryopreservation of human natural killer cell line NK-92 for clinical manufacturing. PloS one 19 (2) (2024)
Jiyun Lee, Hee Kyung Ahn, Sang-We Kim, Ji-Youn Han, Sung Sook Lee, Hyung Soon Park, Hyun Woo Lee, Joo-Hang Kim, Eunhan Cho, Reto Huggenberger, Byoung Chul Cho
Real-world treatment patterns and clinical outcomes in patients with stage III NSCLC in Korea: The KINDLE study. Cancer medicine 13 (7) (2024)
Xiangnan Guan, Ruozhen Hu, Yoonha Choi, Shyam Srivats, Barzin Y Nabet, John Silva, Lisa McGinnis, Robert Hendricks, Katherine Nutsch, Karl L Banta, Ellen Duong, Alexis Dunkle, Patrick S Chang, Chia-Jung Han, Stephanie Mittman, Nandini Molden, Pallavi Daggumati, Wendy Connolly, Melissa Lynne Johnson, Delvys Rodriguez Abreu, Byoung Chul Cho, Antoine Italiano, Ignacio Gil-Bazo, Enriqueta Felip, Ira Mellman, Sanjeev Mariathasan, David S Shames, Raymond Meng, Eugene Y Chiang, Robert J Johnston, Namrata S Patil
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T reg cells. Nature (2024)
Seul Lee, Yunjoo Joo, Eun Ji Lee, Youngseon Byeon, Jae-Hwan Kim, Kyoung-Ho Pyo, Young Seob Kim, Sun Min Lim, Peter Kilbride, Rohin K Iyer, Mingming Li, Mandy C French, Jung-Yub Lee, Jeeheon Kang, Hyesin Byun, Byoung Chul Cho
Successful expansion and cryopreservation of human natural killer cell line NK-92 for clinical manufacturing. PloS one 19 (2) (2024)
Xiangnan Guan, Ruozhen Hu, Yoonha Choi, Shyam Srivats, Barzin Y Nabet, John Silva, Lisa McGinnis, Robert Hendricks, Katherine Nutsch, Karl L Banta, Ellen Duong, Alexis Dunkle, Patrick S Chang, Chia-Jung Han, Stephanie Mittman, Nandini Molden, Pallavi Daggumati, Wendy Connolly, Melissa Lynne Johnson, Delvys Rodriguez Abreu, Byoung Chul Cho, Antoine Italiano, Ignacio Gil-Bazo, Enriqueta Felip, Ira Mellman, Sanjeev Mariathasan, David S Shames, Raymond Meng, Eugene Y Chiang, Robert J Johnston, Namrata S Patil
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T reg cells. Nature (2024)
Xiangnan Guan, Ruozhen Hu, Yoonha Choi, Shyam Srivats, Barzin Y Nabet, John Silva, Lisa McGinnis, Robert Hendricks, Katherine Nutsch, Karl L Banta, Ellen Duong, Alexis Dunkle, Patrick S Chang, Chia-Jung Han, Stephanie Mittman, Nandini Molden, Pallavi Daggumati, Wendy Connolly, Melissa Lynne Johnson, Delvys Rodriguez Abreu, Byoung Chul Cho, Antoine Italiano, Ignacio Gil-Bazo, Enriqueta Felip, Ira Mellman, Sanjeev Mariathasan, David S Shames, Raymond Meng, Eugene Y Chiang, Robert J Johnston, Namrata S Patil
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T reg cells. Nature (2024)
Ying Cheng, David R Spigel, Byoung Chul Cho, Konstantin K Laktionov, Jian Fang, Yuanbin Chen, Yoshitaka Zenke, Ki Hyeong Lee, Qiming Wang, Alejandro Navarro, Reyes Bernabe, Eva Lotte Buchmeier, John Wen-Cheng Chang, Yoshimasa Shiraishi, Sema Sezgin Goksu, Andrzej Badzio, Anhui Shi, Davey B Daniel, Nguyen Thi Thai Hoa, Milada Zemanova, Helen Mann, Hema Gowda, Haiyi Jiang, Suresh Senan, null null
Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer. The New England journal of medicine (2024)
Xiangnan Guan, Ruozhen Hu, Yoonha Choi, Shyam Srivats, Barzin Y Nabet, John Silva, Lisa McGinnis, Robert Hendricks, Katherine Nutsch, Karl L Banta, Ellen Duong, Alexis Dunkle, Patrick S Chang, Chia-Jung Han, Stephanie Mittman, Nandini Molden, Pallavi Daggumati, Wendy Connolly, Melissa Lynne Johnson, Delvys Rodriguez Abreu, Byoung Chul Cho, Antoine Italiano, Ignacio Gil-Bazo, Enriqueta Felip, Ira Mellman, Sanjeev Mariathasan, David S Shames, Raymond Meng, Eugene Y Chiang, Robert J Johnston, Namrata S Patil
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T reg cells. Nature 627 (8004) (2024)
Xiangnan Guan, Ruozhen Hu, Yoonha Choi, Shyam Srivats, Barzin Y Nabet, John Silva, Lisa McGinnis, Robert Hendricks, Katherine Nutsch, Karl L Banta, Ellen Duong, Alexis Dunkle, Patrick S Chang, Chia-Jung Han, Stephanie Mittman, Nandini Molden, Pallavi Daggumati, Wendy Connolly, Melissa Lynne Johnson, Delvys Rodriguez Abreu, Byoung Chul Cho, Antoine Italiano, Ignacio Gil-Bazo, Enriqueta Felip, Ira Mellman, Sanjeev Mariathasan, David S Shames, Raymond Meng, Eugene Y Chiang, Robert J Johnston, Namrata S Patil
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T reg cells. Nature 627 (8004) (2024)
Xiangnan Guan, Ruozhen Hu, Yoonha Choi, Shyam Srivats, Barzin Y Nabet, John Silva, Lisa McGinnis, Robert Hendricks, Katherine Nutsch, Karl L Banta, Ellen Duong, Alexis Dunkle, Patrick S Chang, Chia-Jung Han, Stephanie Mittman, Nandini Molden, Pallavi Daggumati, Wendy Connolly, Melissa Lynne Johnson, Delvys Rodriguez Abreu, Byoung Chul Cho, Antoine Italiano, Ignacio Gil-Bazo, Enriqueta Felip, Ira Mellman, Sanjeev Mariathasan, David S Shames, Raymond Meng, Eugene Y Chiang, Robert J Johnston, Namrata S Patil
Publisher Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T reg cells. Nature (2024)
Byoung Chul Cho, Irene Braña, Beatriz Cirauqui, Sercan Aksoy, Felix Couture, Ruey-Long Hong, Wilson H Miller, Manuel Chaves-Conde, Margarida Teixeira, Lance Leopold, Mihaela Munteanu, Joy Yang Ge, Ramona F Swaby, Brett G M Hughes
Pembrolizumab plus epacadostat in patients with recurrent/metastatic head and neck squamous cell carcinoma (KEYNOTE-669/ECHO-304): a phase 3, randomized, open-label study. BMC cancer 23 (Suppl 1) (2024)
Eun Ji Lee, Seung Yeon Oh, You Won Lee, Ju Young Kim, Min-Je Kim, Tae Ho Kim, Jii Bum Lee, Min Hee Hong, Sun Min Lim, Anke Baum, Lydia Woelflingseder, Harald Engelhardt, Mark Petronczki, Flavio Solca, Mi Ran Yun, Byoung Chul Cho
Discovery of a novel potent EGFR inhibitor against EGFR activating mutations and on-target resistance in NSCLC. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Xiangnan Guan, Ruozhen Hu, Yoonha Choi, Shyam Srivats, Barzin Y Nabet, John Silva, Lisa McGinnis, Robert Hendricks, Katherine Nutsch, Karl L Banta, Ellen Duong, Alexis Dunkle, Patrick S Chang, Chia-Jung Han, Stephanie Mittman, Nandini Molden, Pallavi Daggumati, Wendy Connolly, Melissa Lynne Johnson, Delvys Rodriguez Abreu, Byoung Chul Cho, Antoine Italiano, Ignacio Gil-Bazo, Enriqueta Felip, Ira Mellman, Sanjeev Mariathasan, David S Shames, Raymond Meng, Eugene Y Chiang, Robert J Johnston, Namrata S Patil
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T reg cells. Nature 627 (8004) (2024)
Sun Min Lim, Seong-San Kang, Dong Kwon Kim, Soo-Hwan Lee, Chun-Bong Synn, Sujeong Baek, Seung Min Yang, Yu Jin Han, Mi Hyun Kim, Heekyung Han, Kwangmin Na, Youngtaek Kim, Mi Ran Yun, Seok-Young Kim, Youngseon Byeon, Young Seob Kim, Jii Bum Lee, Min Hee Hong, Joshua C Curtin, Bharvin Patel, Isabelle Bergiers, Kyoung-Ho Pyo, Byoung Chul Cho
Exploration of immune-modulatory effects of amivantamab in combination with pembrolizumab in lung and head and neck squamous cell carcinoma. Cancer research communications (2024)
Hans Prenen, Sanjeev Deva, Bhumsuk Keam, Colin R Lindsay, Iwona Lugowska, James Chih-Hsin Yang, Federico Longo, Maria J de Miguel Luken, Mariano Ponz-Sarvisé, Myung-Ju Ahn, Mahmut Gümüş, Stephane Champiat, Antoine Italiano, Sebastien Salas, Ruth Perets, Cagatay Arslan, Byoung Chul Cho, Stefan Evers, Christophe Boetsch, Daniel Marbach, David Dejardin, Nassim Sleiman, Caroline Ardeshir, Muriel Richard, Jehad Charo, Anton Kraxner, Nino Keshelava, Volker Teichgräber, Victor Moreno
Phase II study to determine the anti-tumor activity and safety of simlukafusp alfa (FAP-IL2v) combined with atezolizumab in esophageal cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Xiangnan Guan, Ruozhen Hu, Yoonha Choi, Shyam Srivats, Barzin Y Nabet, John Silva, Lisa McGinnis, Robert Hendricks, Katherine Nutsch, Karl L Banta, Ellen Duong, Alexis Dunkle, Patrick S Chang, Chia-Jung Han, Stephanie Mittman, Nandini Molden, Pallavi Daggumati, Wendy Connolly, Melissa Lynne Johnson, Delvys Rodriguez Abreu, Byoung Chul Cho, Antoine Italiano, Ignacio Gil-Bazo, Enriqueta Felip, Ira Mellman, Sanjeev Mariathasan, David S Shames, Raymond Meng, Eugene Y Chiang, Robert J Johnston, Namrata S Patil
Author Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T reg cells. Nature (2024)
Ross Andrew Soo, Urania Dafni, Ji-Youn Han, Byoung Chul Cho, Ernest Nadal, Chong Ming Yeo, Enric Carcereny, Javier De Castro Carpeño, Maria Angeles Sala, Linda Coate, Mariano Provencio Pulla, Christian Britschgi, Patrick Vagenknecht, Georgia Dimopoulou, Roswitha Kammler, Stephen P Finn, Solange Peters, Rolf A Stahel
ctDNA dynamics and mechanisms of acquired resistance in patients treated with osimertinib with or without bevacizumab from the randomised phase II ETOP-BOOSTER trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Xiangnan Guan, Ruozhen Hu, Yoonha Choi, Shyam Srivats, Barzin Y Nabet, John Silva, Lisa McGinnis, Robert Hendricks, Katherine Nutsch, Karl L Banta, Ellen Duong, Alexis Dunkle, Patrick S Chang, Chia-Jung Han, Stephanie Mittman, Nandini Molden, Pallavi Daggumati, Wendy Connolly, Melissa Lynne Johnson, Delvys Rodriguez Abreu, Byoung Chul Cho, Antoine Italiano, Ignacio Gil-Bazo, Enriqueta Felip, Ira Mellman, Sanjeev Mariathasan, David S Shames, Raymond Meng, Eugene Y Chiang, Robert J Johnston, Namrata S Patil
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T reg cells. Nature 627 (8004) (2024)
Jiyun Lee, Hee Kyung Ahn, Sang-We Kim, Ji-Youn Han, Sung Sook Lee, Hyung Soon Park, Hyun Woo Lee, Joo-Hang Kim, Eunhan Cho, Reto Huggenberger, Byoung Chul Cho
Real-world treatment patterns and clinical outcomes in patients with stage III NSCLC in Korea: The KINDLE study. Cancer medicine 13 (7) (2024)
Jiyun Lee, Hee Kyung Ahn, Sang-We Kim, Ji-Youn Han, Sung Sook Lee, Hyung Soon Park, Hyun Woo Lee, Joo-Hang Kim, Eunhan Cho, Reto Huggenberger, Byoung Chul Cho
Real-world treatment patterns and clinical outcomes in patients with stage III NSCLC in Korea: The KINDLE study. Cancer medicine 13 (7) (2024)
Su-Jin Choi, Jii Bum Lee, Jae Hwan Kim, Min Hee Hong, Byoung Chul Cho, Sun Min Lim
Analysis of tumor mutational burden and mutational landscape comparing whole-exome sequencing and comprehensive genomic profiling in patients with resectable early-stage non-small-cell lung cancer. Therapeutic advances in medical oncology 16 (2024)
Xiangnan Guan, Ruozhen Hu, Yoonha Choi, Shyam Srivats, Barzin Y Nabet, John Silva, Lisa McGinnis, Robert Hendricks, Katherine Nutsch, Karl L Banta, Ellen Duong, Alexis Dunkle, Patrick S Chang, Chia-Jung Han, Stephanie Mittman, Nandini Molden, Pallavi Daggumati, Wendy Connolly, Melissa Lynne Johnson, Delvys Rodriguez Abreu, Byoung Chul Cho, Antoine Italiano, Ignacio Gil-Bazo, Enriqueta Felip, Ira Mellman, Sanjeev Mariathasan, David S Shames, Raymond Meng, Eugene Y Chiang, Robert J Johnston, Namrata S Patil
Publisher Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T reg cells. Nature (2024)
Sun Min Lim, Seong-San Kang, Dong Kwon Kim, Soo-Hwan Lee, Chun-Bong Synn, Sujeong Baek, Seung Min Yang, Yu Jin Han, Mi Hyun Kim, Heekyung Han, Kwangmin Na, Youngtaek Kim, Mi Ran Yun, Seok-Young Kim, Youngseon Byeon, Young S Kim, Jii Bum Lee, Min Hee Hong, Joshua C Curtin, Bharvin Patel, Isabelle Bergiers, Kyoung-Ho Pyo, Byoung Chul Cho
Exploration of Immune-Modulatory Effects of Amivantamab in Combination with Pembrolizumab in Lung and Head and Neck Squamous Cell Carcinoma. Cancer research communications 4 (7) (2024)
Xiangnan Guan, Ruozhen Hu, Yoonha Choi, Shyam Srivats, Barzin Y Nabet, John Silva, Lisa McGinnis, Robert Hendricks, Katherine Nutsch, Karl L Banta, Ellen Duong, Alexis Dunkle, Patrick S Chang, Chia-Jung Han, Stephanie Mittman, Nandini Molden, Pallavi Daggumati, Wendy Connolly, Melissa Lynne Johnson, Delvys Rodriguez Abreu, Byoung Chul Cho, Antoine Italiano, Ignacio Gil-Bazo, Enriqueta Felip, Ira Mellman, Sanjeev Mariathasan, David S Shames, Raymond Meng, Eugene Y Chiang, Robert J Johnston, Namrata S Patil
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T reg cells. Nature 627 (8004) (2024)
Eun Ji Lee, Seung Yeon Oh, You Won Lee, Ju Young Kim, Min-Je Kim, Tae Ho Kim, Jii Bum Lee, Min Hee Hong, Sun Min Lim, Anke Baum, Lydia Woelflingseder, Harald Engelhardt, Mark Petronczki, Flavio Solca, Mi Ran Yun, Byoung Chul Cho
Discovery of a Novel Potent EGFR Inhibitor Against EGFR Activating Mutations and On-Target Resistance in NSCLC. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Sun Min Lim, Seong-San Kang, Dong Kwon Kim, Soo-Hwan Lee, Chun-Bong Synn, Sujeong Baek, Seung Min Yang, Yu Jin Han, Mi Hyun Kim, Heekyung Han, Kwangmin Na, Youngtaek Kim, Mi Ran Yun, Seok-Young Kim, Youngseon Byeon, Young S Kim, Jii Bum Lee, Min Hee Hong, Joshua C Curtin, Bharvin Patel, Isabelle Bergiers, Kyoung-Ho Pyo, Byoung Chul Cho
Exploration of Immune-Modulatory Effects of Amivantamab in Combination with Pembrolizumab in Lung and Head and Neck Squamous Cell Carcinoma. Cancer research communications 4 (7) (2024)
Byoung Chul Cho, Shun Lu, Enriqueta Felip, Alexander I Spira, Nicolas Girard, Jong-Seok Lee, Se-Hoon Lee, Yurii Ostapenko, Pongwut Danchaivijitr, Baogang Liu, Adlinda Alip, Ernesto Korbenfeld, Josiane Mourão Dias, Benjamin Besse, Ki-Hyeong Lee, Hailin Xiong, Soon-Hin How, Ying Cheng, Gee-Chen Chang, Hiroshige Yoshioka, James C-H Yang, Michael Thomas, Danny Nguyen, Sai-Hong I Ou, Sanjay Mukhedkar, Kumar Prabhash, Manolo D'Arcangelo, Jorge Alatorre-Alexander, Juan C Vázquez Limón, Sara Alves, Daniil Stroyakovskiy, Marina Peregudova, Mehmet A N Şendur, Ozan Yazici, Raffaele Califano, Vanesa Gutiérrez Calderón, Filippo de Marinis, Antonio Passaro, Sang-We Kim, Shirish M Gadgeel, John Xie, Tao Sun, Melissa Martinez, Mariah Ennis, Elizabeth Fennema, Mahesh Daksh, Dawn Millington, Isabelle Leconte, Ryota Iwasawa, Patricia Lorenzini, Mahadi Baig, Sujay Shah, Joshua M Bauml, S Martin Shreeve, Seema Sethi, Roland E Knoblauch, Hidetoshi Hayashi, null null
Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC. The New England journal of medicine (2024)
Xiangnan Guan, Ruozhen Hu, Yoonha Choi, Shyam Srivats, Barzin Y Nabet, John Silva, Lisa McGinnis, Robert Hendricks, Katherine Nutsch, Karl L Banta, Ellen Duong, Alexis Dunkle, Patrick S Chang, Chia-Jung Han, Stephanie Mittman, Nandini Molden, Pallavi Daggumati, Wendy Connolly, Melissa Lynne Johnson, Delvys Rodriguez Abreu, Byoung Chul Cho, Antoine Italiano, Ignacio Gil-Bazo, Enriqueta Felip, Ira Mellman, Sanjeev Mariathasan, David S Shames, Raymond Meng, Eugene Y Chiang, Robert J Johnston, Namrata S Patil
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T reg cells. Nature 627 (8004) (2024)
Su-Jin Choi, Jii Bum Lee, Jae Hwan Kim, Min Hee Hong, Byoung Chul Cho, Sun Min Lim
Analysis of tumor mutational burden and mutational landscape comparing whole-exome sequencing and comprehensive genomic profiling in patients with resectable early-stage non-small-cell lung cancer. Therapeutic advances in medical oncology 16 (2024)
Xiangnan Guan, Ruozhen Hu, Yoonha Choi, Shyam Srivats, Barzin Y Nabet, John Silva, Lisa McGinnis, Robert Hendricks, Katherine Nutsch, Karl L Banta, Ellen Duong, Alexis Dunkle, Patrick S Chang, Chia-Jung Han, Stephanie Mittman, Nandini Molden, Pallavi Daggumati, Wendy Connolly, Melissa Lynne Johnson, Delvys Rodriguez Abreu, Byoung Chul Cho, Antoine Italiano, Ignacio Gil-Bazo, Enriqueta Felip, Ira Mellman, Sanjeev Mariathasan, David S Shames, Raymond Meng, Eugene Y Chiang, Robert J Johnston, Namrata S Patil
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T reg cells. Nature 627 (8004) (2024)
Fabrice Barlesi, Byoung Chul Cho, Sarah B Goldberg, Kiyotaka Yoh, Ana Caroline Zimmer Gelatti, Helen Mann, Aarthi Gopinathan, Zofia Felicja Bielecka, Michael Newton, Charu Aggarwal
PACIFIC-9: Phase III trial of durvalumab + oleclumab or monalizumab in unresectable stage III non-small-cell lung cancer. Future oncology (London, England) (2024)
Xiangnan Guan, Ruozhen Hu, Yoonha Choi, Shyam Srivats, Barzin Y Nabet, John Silva, Lisa McGinnis, Robert Hendricks, Katherine Nutsch, Karl L Banta, Ellen Duong, Alexis Dunkle, Patrick S Chang, Chia-Jung Han, Stephanie Mittman, Nandini Molden, Pallavi Daggumati, Wendy Connolly, Melissa Lynne Johnson, Delvys Rodriguez Abreu, Byoung Chul Cho, Antoine Italiano, Ignacio Gil-Bazo, Enriqueta Felip, Ira Mellman, Sanjeev Mariathasan, David S Shames, Raymond Meng, Eugene Y Chiang, Robert J Johnston, Namrata S Patil
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T reg cells. Nature 627 (8004) (2024)
Xiangnan Guan, Ruozhen Hu, Yoonha Choi, Shyam Srivats, Barzin Y Nabet, John Silva, Lisa McGinnis, Robert Hendricks, Katherine Nutsch, Karl L Banta, Ellen Duong, Alexis Dunkle, Patrick S Chang, Chia-Jung Han, Stephanie Mittman, Nandini Molden, Pallavi Daggumati, Wendy Connolly, Melissa Lynne Johnson, Delvys Rodriguez Abreu, Byoung Chul Cho, Antoine Italiano, Ignacio Gil-Bazo, Enriqueta Felip, Ira Mellman, Sanjeev Mariathasan, David S Shames, Raymond Meng, Eugene Y Chiang, Robert J Johnston, Namrata S Patil
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T reg cells. Nature 627 (8004) (2024)
Moonki Hong, Sang Wook Lee, Byoung Chul Cho, Min Hee Hong, Sun Min Lim, Nak-Jung Kwon
Multiplex analysis for the identification of plasma protein biomarkers for predicting lung cancer immunotherapy response. Therapeutic advances in medical oncology 16 (2024)
Hans Prenen, Sanjeev Deva, Bhumsuk Keam, Colin R Lindsay, Iwona Lugowska, James Chih-Hsin Yang, Federico Longo, Maria J de Miguel Luken, Mariano Ponz-Sarvisé, Myung-Ju Ahn, Mahmut Gümüş, Stephane Champiat, Antoine Italiano, Sebastien Salas, Ruth Perets, Cagatay Arslan, Byoung Chul Cho, Stefan Evers, Christophe Boetsch, Daniel Marbach, David Dejardin, Nassim Sleiman, Caroline Ardeshir, Muriel Richard, Jehad Charo, Anton Kraxner, Nino Keshelava, Volker Teichgräber, Victor Moreno
Phase II Study to Determine the Antitumor Activity and Safety of Simlukafusp Alfa (FAP-IL2v) Combined with Atezolizumab in Esophageal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Sun Min Lim, Seong-San Kang, Dong Kwon Kim, Soo-Hwan Lee, Chun-Bong Synn, Sujeong Baek, Seung Min Yang, Yu Jin Han, Mi Hyun Kim, Heekyung Han, Kwangmin Na, Youngtaek Kim, Mi Ran Yun, Seok-Young Kim, Youngseon Byeon, Young S Kim, Jii Bum Lee, Min Hee Hong, Joshua C Curtin, Bharvin Patel, Isabelle Bergiers, Kyoung-Ho Pyo, Byoung Chul Cho
Exploration of Immune-Modulatory Effects of Amivantamab in Combination with Pembrolizumab in Lung and Head and Neck Squamous Cell Carcinoma. Cancer research communications 4 (7) (2024)
Xiangnan Guan, Ruozhen Hu, Yoonha Choi, Shyam Srivats, Barzin Y Nabet, John Silva, Lisa McGinnis, Robert Hendricks, Katherine Nutsch, Karl L Banta, Ellen Duong, Alexis Dunkle, Patrick S Chang, Chia-Jung Han, Stephanie Mittman, Nandini Molden, Pallavi Daggumati, Wendy Connolly, Melissa Lynne Johnson, Delvys Rodriguez Abreu, Byoung Chul Cho, Antoine Italiano, Ignacio Gil-Bazo, Enriqueta Felip, Ira Mellman, Sanjeev Mariathasan, David S Shames, Raymond Meng, Eugene Y Chiang, Robert J Johnston, Namrata S Patil
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T reg cells. Nature 627 (8004) (2024)
Xiangnan Guan, Ruozhen Hu, Yoonha Choi, Shyam Srivats, Barzin Y Nabet, John Silva, Lisa McGinnis, Robert Hendricks, Katherine Nutsch, Karl L Banta, Ellen Duong, Alexis Dunkle, Patrick S Chang, Chia-Jung Han, Stephanie Mittman, Nandini Molden, Pallavi Daggumati, Wendy Connolly, Melissa Lynne Johnson, Delvys Rodriguez Abreu, Byoung Chul Cho, Antoine Italiano, Ignacio Gil-Bazo, Enriqueta Felip, Ira Mellman, Sanjeev Mariathasan, David S Shames, Raymond Meng, Eugene Y Chiang, Robert J Johnston, Namrata S Patil
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T reg cells. Nature 627 (8004) (2024)
Seul Lee, Yunjoo Joo, Eun Ji Lee, Youngseon Byeon, Jae-Hwan Kim, Kyoung-Ho Pyo, Young Seob Kim, Sun Min Lim, Peter Kilbride, Rohin K Iyer, Mingming Li, Mandy C French, Jung-Yub Lee, Jeeheon Kang, Hyesin Byun, Byoung Chul Cho
Successful expansion and cryopreservation of human natural killer cell line NK-92 for clinical manufacturing. PloS one 19 (2) (2024)
Jing Zhang, Sun Min Lim, Mi Ra Yu, Cheng Chen, Jia Wang, Wenqian Wang, Haopeng Rui, Jingtao Lu, Shun Lu, Tony S K Mok, Zhi Jian Chen, Byoung Chul Cho
D3S-001, a KRAS G12C inhibitor with rapid target engagement kinetics, overcomes nucleotide cycling and demonstrates robust preclinical and clinical activities. Cancer discovery (2024)
Eun Ji Lee, Seung Yeon Oh, You Won Lee, Ju Young Kim, Min-Je Kim, Tae Ho Kim, Jii Bum Lee, Min Hee Hong, Sun Min Lim, Anke Baum, Lydia Woelflingseder, Harald Engelhardt, Mark Petronczki, Flavio Solca, Mi Ran Yun, Byoung Chul Cho
Discovery of a Novel Potent EGFR Inhibitor Against EGFR Activating Mutations and On-Target Resistance in NSCLC. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Daniel Shao-Weng Tan, Enriqueta Felip Font, Gilberto de Castro Junior, Benjamin J Solomon, Alastair P Greystoke, Byoung Chul Cho, Manuel Cobo, Tae Min Kim, Sandip Ganguly, Enric Carcereny, Luis G Paz-Ares, Jaafar Bennouna, Marina-Chiara Garassino, Michael Schenker, Sang-We Kim, Jan C Brase, Denise Bury-Maynard, Vanessa Q Passos, Stéphanie Deudon, Bharani Dharan, Yuanbo Song, Rafael Caparica, Bruce E Johnson
Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Results From the CANOPY-1 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Edward B Garon, Shun Lu, Yasushi Goto, Pedro De Marchi, Luis G Paz-Ares, David R Spigel, Michael Thomas, James Chih-Hsin Yang, Andrea Ardizzoni, Fabrice Barlesi, Sergey V Orlov, Hiroshige Yoshioka, Giannis Mountzios, Sadhvi Khanna, Claudia Bossen, Mariana Carbini, Sabine Turri, Andrea Myers, Byoung Chul Cho
Canakinumab as Adjuvant Therapy in Patients With Completely Resected Non-Small-Cell Lung Cancer: Results From the CANOPY-A Double-Blind, Randomized Clinical Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Juliann Chmielecki, Jhanelle E Gray, Ying Cheng, Yuichiro Ohe, Fumio Imamura, Byoung Chul Cho, Meng-Chih Lin, Margarita Majem, Riyaz Shah, Yuri Rukazenkov, Alexander Todd, Aleksandra Markovets, J Carl Barrett, Ryan J Hartmaier, Suresh R Ramalingam
Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer. Nature communications 14 (1) (2023)
Juliann Chmielecki, Jhanelle E Gray, Ying Cheng, Yuichiro Ohe, Fumio Imamura, Byoung Chul Cho, Meng-Chih Lin, Margarita Majem, Riyaz Shah, Yuri Rukazenkov, Alexander Todd, Aleksandra Markovets, J Carl Barrett, Ryan J Hartmaier, Suresh R Ramalingam
Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer. Nature communications 14 (1) (2023)
Jia Li Low, Sun Min Lim, Jii Bum Lee, Byoung Chul Cho, Ross A Soo
Advances in the management of non-small-cell lung cancer harbouring EGFR exon 20 insertion mutations. Therapeutic advances in medical oncology 15 (2023)
Jhanelle E Gray, Myung-Ju Ahn, Geoffrey R Oxnard, Frances A Shepherd, Fumio Imamura, Ying Cheng, Isamu Okamoto, Byoung Chul Cho, Meng-Chih Lin, Yi-Long Wu, Margarita Majem Tarruella, Oliver Gautschi, Michael J Boyer, Krishna C Bulusu, Aleksandra A Markovets, J Carl Barrett, Rachel Hodge, Astrid McKeown, Ryan J Hartmaier, Juliann Chmielecki, Vassiliki A Papadimitrakopoulou, Suresh R Ramalingam
Early Clearance of Plasma Epidermal Growth Factor Receptor Mutations as a Predictor of Outcome on Osimertinib in Advanced Non-Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURA. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Juliann Chmielecki, Jhanelle E Gray, Ying Cheng, Yuichiro Ohe, Fumio Imamura, Byoung Chul Cho, Meng-Chih Lin, Margarita Majem, Riyaz Shah, Yuri Rukazenkov, Alexander Todd, Aleksandra Markovets, J Carl Barrett, Ryan J Hartmaier, Suresh R Ramalingam
Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer. Nature communications 14 (1) (2023)
Jia Li Low, Sun Min Lim, Jii Bum Lee, Byoung Chul Cho, Ross A Soo
Advances in the management of non-small-cell lung cancer harbouring EGFR exon 20 insertion mutations. Therapeutic advances in medical oncology 15 (2023)
Byoung Chul Cho, Dong Wan Kim, Alexander I Spira, Jorge E Gomez, Eric B Haura, Sang-We Kim, Rachel E Sanborn, Eun Kyung Cho, Ki Hyeong Lee, Anna R Minchom, Jong-Seok Lee, Ji-Youn Han, Misako Nagasaka, Joshua K Sabari, Sai-Hong Ignatius Ou, Patricia Lorenzini, Joshua M Bauml, Joshua C Curtin, Amy Roshak, Grace Gao, John Xie, Meena Thayu, Roland E Knoblauch, Keunchil Park
Amivantamab plus lazertinib in osimertinib-relapsed EGFR-mutant advanced non-small cell lung cancer: a phase 1 trial. Nature medicine (2023)
Byoung Chul Cho, Myung-Ju Ahn, Jin Hyoung Kang, Ross Andrew Soo, Thanyanan Reungwetwattana, James Chih-Hsin Yang, Irfan Cicin, Dong Wan Kim, Yi-Long Wu, Shun Lu, Ki Hyeong Lee, Yong-Kek Pang, Anastasia Zimina, Chin Heng Fong, Elena Poddubskaya, Ahmet Sezer, Soon Hin How, Pongwut Danchaivijitr, YuKyung Kim, Yeji Lim, Taewon An, Hana Lee, Hae Mi Byun, Bojan Zarić
Lazertinib Versus Gefitinib as First-line Treatment in Patients With EGFR -mutated Advanced Non-Small Cell Lung Cancer (NSCLC): Results From LASER301. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Juliann Chmielecki, Jhanelle E Gray, Ying Cheng, Yuichiro Ohe, Fumio Imamura, Byoung Chul Cho, Meng-Chih Lin, Margarita Majem, Riyaz Shah, Yuri Rukazenkov, Alexander Todd, Aleksandra Markovets, J Carl Barrett, Ryan J Hartmaier, Suresh R Ramalingam
Author Correction: Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer. Nature communications 14 (1) (2023)
Juliann Chmielecki, Jhanelle E Gray, Ying Cheng, Yuichiro Ohe, Fumio Imamura, Byoung Chul Cho, Meng-Chih Lin, Margarita Majem, Riyaz Shah, Yuri Rukazenkov, Alexander Todd, Aleksandra Markovets, J Carl Barrett, Ryan J Hartmaier, Suresh R Ramalingam
Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer. Nature communications 14 (1) (2023)
Morihito Okada, Ken Kato, Byoung Chul Cho, Masanobu Takahashi, Chen-Yuan Lin, Keisho Chin, Shigenori Kadowaki, Myung-Ju Ahn, Yasuo Hamamoto, Yuichiro Doki, Chueh-Chuan Yen, Yutaro Kubota, Sung-Bae Kim, Chih-Hung Hsu, Eva Holtved, Ioannis Xynos, Yasuhiro Matsumura, Akira Takazawa, Yuko Kitagawa
Three-Year Follow-Up and Response-Survival Relationship of Nivolumab in Previously Treated Patients with Advanced Esophageal Squamous Cell Carcinoma (ATTRACTION-3). Clinical cancer research : an official journal of the American Association for Cancer Research 28 (15) (2022)
Seung Yeon Oh, You Won Lee, Eun Ji Lee, Seok-Young Kim, Young Joon Park, Seong Gu Heo, Mi Ra Yu, Min Hee Hong, John O DaSilva, Christopher Daly, Byoung Chul Cho, Sun Min Lim, Mi Ran Yun
Preclinical study of a biparatopic METxMET Antibody-Drug Conjugate, REGN5093-M114, overcomes MET-driven acquired resistance to EGFR TKIs in EGFR-mutant NSCLC. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Jiyun Lee, Min Hee Hong, Byoung Chul Cho
Lazertinib: on the Way to Its Throne. Yonsei medical journal 63 (9) (2022)
Ryan J Hartmaier, Aleksandra A Markovets, Myung-Ju Ahn, Lecia V Sequist, Ji-Youn Han, Byoung Chul Cho, Helena Alexandra Yu, Sang-We Kim, James Chih-Hsin Yang, Jong Seok Lee, Wu-Chou Su, Dariusz Mirosław Kowalski, Sergey V Orlov, Song Ren, Paul Frewer, Xiaoling Ou, Darren Ae Cross, Nisha Kurian, Mireille Cantarini, Pasi A Janne
Osimertinib+Savolitinib to Overcome Acquired MET-Mediated Resistance in Epidermal Growth Factor Receptor Mutated MET-Amplified Non-Small Cell Lung Cancer: TATTON. Cancer discovery (2022)
Sun Min Lim, Chang Gon Kim, Jii Bum Lee, Byoung Chul Cho
Patritumab Deruxtecan: Paving the Way for EGFR-TKI-Resistant NSCLC. Cancer discovery 12 (1) (2022)
Jii Bum Lee, Hyung Soon Park, Su Jin Choi, Seong Gu Heo, Ho Jung An, Hye Ryun Kim, Min Hee Hong, Sun Min Lim, Kyle Chang, Katie Quinn, Justin Odegaard, Byoung Yong Shim, Byoung Chul Cho
Plasma tumor mutation burden is associated with clinical benefit in patients with non-small cell lung cancer treated with anti-programmed death-1 monotherapy. Therapeutic advances in medical oncology 14 (2022)
Abdul Rahman Jazieh, Huseyin Cem Onal, Daniel Shao-Weng Tan, Ross A Soo, Kumar Prabhash, Amit Kumar, Reto Huggenberger, Byoung Chul Cho
Real-world global data on targeting epidermal growth factor receptor mutations in stage III non-small-cell lung cancer: the results of the KINDLE study. Therapeutic advances in medical oncology 14 (2022)
Gilberto de Castro Junior, Iveta Kudaba, Yi-Long Wu, Gilberto de Lima Lopes, Dariusz Mirosław Kowalski, Hande Z Turna, Christian Caglevic, Li Zhang, Boguslawa Karaszewska, Konstantin K Laktionov, Vichien Srimuninnimit, Igor Bondarenko, Kaoru Kubota, Rinee Mukherjee, Jianxin Lin, Fabricio Souza, Tony S K Mok, Byoung Chul Cho
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy as First-Line Therapy in Patients With Non-Small-Cell Lung Cancer and Programmed Death Ligand-1 Tumor Proportion Score ≥ 1% in the KEYNOTE-042 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Jiyun Lee, Zofia Piotrowska, Ross Soo, Byoung Chul Cho, Sun Min Lim
Combatting acquired resistance to osimertinib in EGFR-mutant lung cancer. Therapeutic advances in medical oncology 14 (2022)
David R Spigel, Corinne Faivre-Finn, Jhanelle E Gray, David Vicente, David Planchard, Luis G Paz-Ares, Johan Filip Vansteenkiste, Marina-Chiara Garassino, Rina Hui, Xavier Quantin, Andreas Rimner, Yi-Long Wu, Mustafa Özgüroğlu, Ki Hyeong Lee, Terufumi Kato, Maike de Wit, Takayasu Kurata, Martin Reck, Byoung Chul Cho, Suresh Senan, Jarushka Naidoo, Helen Mann, Michael Newton, Piruntha Thiyagarajah, Scott J Antonia
Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (12) (2022)
Melissa Lynne Johnson, Byoung Chul Cho, Alexander Luft, Jorge Alatorre-Alexander, Sarayut Lucien Geater, Konstantin Laktionov, Sang-We Kim, Grygorii Ursol, Maen Hussein, Farah Louise Lim, Cheng-Ta Yang, Luiz Henrique Araujo, Haruhiro Saito, Niels Reinmuth, Xiaojin Shi, Lynne Poole, Solange Peters, Edward B Garon, Tony S K Mok, null null
Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: The Phase III POSEIDON Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Jiyun Lee, Zofia Piotrowska, Ross Soo, Byoung Chul Cho, Sun Min Lim
Combatting acquired resistance to osimertinib in EGFR-mutant lung cancer. Therapeutic advances in medical oncology 14 (2022)
Sun Min Lim, Chang Gon Kim, Byoung Chul Cho
Antibody-Drug Conjugates: A New Addition to the Treatment Landscape of EGFR-Mutant Non-Small Cell Lung Cancer. Cancer research 82 (1) (2022)
George D Demetri, Filippo De Braud, Alexander E Drilon, Salvatore Siena, Manish R Patel, Byoung Chul Cho, Stephen V Liu, Myung-Ju Ahn, Chao-Hua Chiu, Jessica J Lin, Koichi Goto, Jeeyun Lee, Lyudmila Bazhenova, Thomas John, Marwan Fakih, Sant P Chawla, Rafal Dziadziuszko, Takashi Seto, Sebastian Heinzmann, Bethany Pitcher, David Chen, Timothy R Wilson, Christian Rolfo
Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients With NTRK Fusion-Positive Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (7) (2022)
Jii Bum Lee, Hyung Soon Park, Su Jin Choi, Seong Gu Heo, Ho Jung An, Hye Ryun Kim, Min Hee Hong, Sun Min Lim, Kyle Chang, Katie Quinn, Justin Odegaard, Byoung Yong Shim, Byoung Chul Cho
Plasma tumor mutation burden is associated with clinical benefit in patients with non-small cell lung cancer treated with anti-programmed death-1 monotherapy. Therapeutic advances in medical oncology 14 (2022)
Vivek Subbiah, Justin F Gainor, Geoffrey R Oxnard, Daniel S W Tan, Dwight H Owen, Byoung Chul Cho, Herbert Ho-Fung Loong, Caroline E McCoach, Jared Weiss, Yu Jung Kim, Lyudmila Bazhenova, Keunchil Park, Haruko Daga, Benjamin Besse, Oliver Gautschi, Christian C Rolfo, Edward Y Zhu, Jennifer F Kherani, Xin Huang, Suhyun Kang, Alexander E Drilon
Intracranial Efficacy of Selpercatinib in RET Fusion-Positive Non-Small Cell Lung Cancers on the LIBRETTO-001 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (15) (2021)
Kyoung-Ho Pyo, Sun Min Lim, Chae-Won Park, Ha-Ni Jo, Jae Hwan Kim, Mi-Ran Yun, Dohee Kim, Chun-Feng Xin, Wongeun Lee, Bianca Gheorghiu, Min Hee Hong, Hye Ryun Kim, Hyo Sup Shim, Mi Jang, Sung Sook Lee, Byoung Chul Cho
Comprehensive analyses of immunodynamics and immunoreactivity in response to treatment in ALK-positive non-small-cell lung cancer. Journal for immunotherapy of cancer 8 (2) (2021)
Keunchil Park, Eric B Haura, Natasha B Leighl, Paul Mitchell, Catherine A Shu, Nicolas Girard, Santiago Viteri, Ji-Youn Han, Sang-We Kim, Chee Khoon Lee, Joshua K Sabari, Alexander I Spira, Tsung-Ying Yang, Dong Wan Kim, Ki Hyeong Lee, Rachel E Sanborn, José Trigo, Koichi Goto, Jong-Seok Lee, James Chih-Hsin Yang, Ramaswamy Govindan, Joshua M Bauml, Pilar Garrido Lopez, Matthew G Krebs, Karen L Reckamp, John Xie, Joshua C Curtin, Nahor Haddish-Berhane, Amy Roshak, Dawn Millington, Patricia Lorenzini, Meena Thayu, Roland E Knoblauch, Byoung Chul Cho
Amivantamab in EGFR Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (30) (2021)
Chun-Bong Synn, Sung Eun Kim, Hee Kyu Lee, Min-Hwan Kim, Jae Hwan Kim, Ji Min Lee, Ha Ni Jo, Wongeun Lee, Dong Kwon Kim, Youngseon Byeon, Young Seob Kim, Mi Ran Yun, Chae-Won Park, Jiyeon Yun, Sangbin Lim, Seong Gu Heo, San-Duk Yang, Eun Ji Lee, Seul Lee, Hunmi Choi, You Won Lee, Jae Seok Cho, Do Hee Kim, Sungho Park, Jung-Ho Kim, Yewon Choi, Sung Sook Lee, Beung Chul Ahn, Chang Gon Kim, Sun Min Lim, Min Hee Hong, Hye Ryun Kim, Kyoung-Ho Pyo, Byoung Chul Cho
SKI-G-801, an AXL kinase inhibitor, blocks metastasis through inducing anti-tumor immune responses and potentiates anti-PD-1 therapy in mouse cancer models. Clinical & translational immunology 11 (1) (2021)
Rafal Dziadziuszko, Matthew G Krebs, Filippo De Braud, Salvatore Siena, Alexander E Drilon, Robert C Doebele, Manish R Patel, Byoung Chul Cho, Stephen V Liu, Myung-Ju Ahn, Chao-Hua Chiu, Anna F Farago, Chia-Chi Lin, Christos S Karapetis, Yu-Chung Li, Bann-Mo Day, David Chen, Timothy R Wilson, Fabrice Barlesi
Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic ROS1 Fusion-Positive Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (11) (2021)
Julius Strauss, Margaret E Gatti-Mays, Byoung Chul Cho, Andrew Hill, Sébastien Salas, Edward McClay, Jason M Redman, Houssein Abdul Sater, Renee N Donahue, Caroline Jochems, Elizabeth Lamping, Andrea Burmeister, Jennifer L Marté, Lisa M Cordes, Marijo Bilusic, Fatima Karzai, Laureen S Ojalvo, Genevieve Jehl, P Alexander Rolfe, Christian S Hinrichs, Ravi A Madan, Jeffrey Schlom, James L Gulley
Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies. Journal for immunotherapy of cancer 8 (2) (2021)
Seok-Young Kim, Sang-Min Kim, Sumin Lim, Ji Yeon Lee, Su-Jin Choi, San-Duk Yang, Mi Ran Yun, Chang Gon Kim, Seo Rin Gu, Chaewon Park, A-Young Park, Sun Min Lim, Seong Gu Heo, HyunKi Kim, Byoung Chul Cho
Modeling Clinical Responses to Targeted Therapies by Patient-Derived Organoids of Advanced Lung Adenocarcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (15) (2021)
Byoung Chul Cho, Amaury Daste, Alain Ravaud, Sébastien Salas, Nicolas Isambert, Edward McClay, Ahmad Awada, Christian Borel, Laureen S Ojalvo, Christoph Helwig, P Alexander Rolfe, James L Gulley, Nicolas Penel
Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in advanced squamous cell carcinoma of the head and neck: results from a phase I cohort. Journal for immunotherapy of cancer 8 (2) (2021)
Byoung Chul Cho, Enriqueta Felip, Hidetoshi Hayashi, Michael Thomas, Shun Lu, Benjamin Besse, Tao Sun, Melissa Martinez, Seema N Sethi, S Martin Shreeve, Alexander I Spira
MARIPOSA: phase 3 study of first-line amivantamab + lazertinib versus osimertinib in EGFR-mutant non-small-cell lung cancer. Future oncology (London, England) 18 (6) (2021)
Xiuning Li, Hiroshi Sakai, Enriqueta Felip, Remi Veillon, Marina Chiara Garassino, Jo Raskin, Alexis B Cortot, Santiago Viteri, Julien Mazieres, Egbert F Smit, Michael Thomas, Wade T Iams, Byoung Chul Cho, Hye Ryun Kim, James Chih-Hsin Yang, Yuh-Min Chen, Jyoti D Patel, Christine M Bestvina, Keunchil Park, Frank Griesinger, Melissa Johnson, Maya Gottfried, Christian Britschgi, John Victor Heymach, Elif Sikoglu, Karin Berghoff, Karl-Maria Schumacher, Rolf Bruns, Gordon Otto, Paul K Paik
Tepotinib Efficacy and Safety in Patients with MET Exon 14 Skipping NSCLC: Outcomes in Patient Subgroups from the VISION Study with Relevance for Clinical Practice. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Hye Ryun Kim, Han Na Kang, Mi Ran Yun, Kwon Young Ju, Jae Woo Choi, Dong Min Jung, Kyoung Ho Pyo, Min Hee Hong, Myoung-Ju Ahn, Jong-Mu Sun, Han Sang Kim, Jinna Kim, Jinseon Yoo, Kyu Ryung Kim, Yoon Woo Koh, Se Heon Kim, Eun Chang Choi, Sun Ock Yoon, Hyo Sup Shim, Soonmyung Paik, Tae-Min Kim, Byoung Chul Cho
Mouse-human co-clinical trials demonstrate superior anti-tumour effects of buparlisib (BKM120) and cetuximab combination in squamous cell carcinoma of head and neck. British journal of cancer 123 (12) (2020)
You Jin Chun, Jae Woo Choi, Min Hee Hong, Dongmin Jung, Hyeonju Son, Eun Kyung Cho, Young Joo Min, Sang-We Kim, Keunchil Park, Sung Sook Lee, Sangwoo Kim, Hye Ryun Kim, Byoung Chul Cho, null null
Molecular characterization of lung adenocarcinoma from Korean patients using next generation sequencing. PloS one 14 (11) (2019)
Mi Ran Yun, Hun Mi Choi, You Won Lee, Hyeong Seok Joo, Chae Won Park, Jae Woo Choi, Dong Hwi Kim, Han Na Kang, Kyoung-Ho Pyo, Eun Joo Shin, Hyo Sup Shim, Ross A Soo, James Chih-Hsin Yang, Sung Sook Lee, Hyun Chang, Min Hwan Kim, Min Hee Hong, Hye Ryun Kim, Byoung Chul Cho
Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK-rearranged lung cancer. EMBO molecular medicine 11 (12) (2019)
Min Hee Hong, Hye Ryun Kim, Beung Chul Ahn, Su Jin Heo, Ji Hyoung Kim, Byoung Chul Cho
Real-World Analysis of the Efficacy of Rebiopsy and EGFR Mutation Test of Tissue and Plasma Samples in Drug-Resistant Non-Small Cell Lung Cancer. Yonsei medical journal 60 (6) (2019)

Byoung Chul Cho.css-eqlu8i{font-size:small;padding-left:4px;} (Byoung C Cho)

Publication Activity (10 Years)

Top Topics

Top Venues

Byoung Chul Cho (Byoung C Cho)